Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine
Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country. It is to be noted that Pfizer India’s parent company Pfizer has already got emergency-use clearance in the United Kingdom and Bahrain.
According to an official source, “Pfizer India has sought permission for emergency usage authorisation of its Covid-19 from DGCI to import and market.” The application was submitted by Pfizer India on December 4 to the DCGI seeking emergency use authorization (EUA) for its vaccine in India.
Pfizer India has submitted the EUA application in Form CT-18 for grant of permission to import and market Pfizer-BioNTech’s Covid-19 vaccine in India. The extremely low temperature of minus 70 degrees Celsius, required for storing the vaccine poses a big challenge for its delivery in a country like India.
Tap To Explore More : Outlook